Literature DB >> 11906000

Functional effects of tau gene mutations deltaN296 and N296H.

Hirotaka Yoshida1, R Anthony Crowther, Michel Goedert.   

Abstract

Mutations in the tau gene cause frontotemporal dementia and parkinsonism linked to chromosome-17 (FTDP-17). Functionally, about half of the known mutations increase the alternative mRNA splicing of exon 10 of the tau gene, resulting in the overproduction of tau isoforms with four microtubule-binding repeats. The other mutations reduce the ability of tau to interact with microtubules, with some mutations also increasing the propensity of tau to assemble into filaments. Here we have examined the functional effects of the recently described tau gene mutations deltaN296 and N296H. Both mutations reduced the ability of tau to promote microtubule assembly, without having a significant effect on tau filament formation. By exon trapping, they increased the splicing of exon 10. DeltaN296 and N296H thus define a class of tau mutations with effects at both the RNA and the protein level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906000     DOI: 10.1046/j.0022-3042.2001.00729.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

Review 1.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

2.  Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation.

Authors:  Shotaro Shimonaka; Shin-Ei Matsumoto; Montasir Elahi; Koichi Ishiguro; Masato Hasegawa; Nobutaka Hattori; Yumiko Motoi
Journal:  J Biol Chem       Date:  2020-08-05       Impact factor: 5.157

Review 3.  Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.

Authors:  Tara M Caffrey; Richard Wade-Martins
Journal:  Neurobiol Dis       Date:  2007-05-05       Impact factor: 5.996

4.  Structural disorder in four-repeat Tau fibrils reveals a new mechanism for barriers to cross-seeding of Tau isoforms.

Authors:  Hilary A Weismiller; Rachel Murphy; Guanghong Wei; Buyong Ma; Ruth Nussinov; Martin Margittai
Journal:  J Biol Chem       Date:  2018-09-21       Impact factor: 5.157

Review 5.  Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?

Authors:  Seyedeh Maryam Alavi Naini; Nadia Soussi-Yanicostas
Journal:  Oxid Med Cell Longev       Date:  2015-10-20       Impact factor: 6.543

6.  Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau-/- mice.

Authors:  Mariana Vargas-Caballero; Franziska Denk; Heike J Wobst; Emily Arch; Chrysia-Maria Pegasiou; Peter L Oliver; Olivia A Shipton; Ole Paulsen; Richard Wade-Martins
Journal:  Front Neurosci       Date:  2017-04-24       Impact factor: 4.677

7.  A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone.

Authors:  Shahin Zibaee; O Sumner Makin; Michel Goedert; Louise C Serpell
Journal:  Protein Sci       Date:  2007-05       Impact factor: 6.725

Review 8.  Tau protein in familial and sporadic diseases.

Authors:  Despina Yancopoulou; Maria Grazia Spillantini
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 4.103

Review 9.  Frontotemporal lobar degeneration: old knowledge and new insight into the pathogenetic mechanisms of tau mutations.

Authors:  Giacomina Rossi; Fabrizio Tagliavini
Journal:  Front Aging Neurosci       Date:  2015-10-14       Impact factor: 5.750

10.  The novel MAPT mutation K298E: mechanisms of mutant tau toxicity, brain pathology and tau expression in induced fibroblast-derived neurons.

Authors:  Mariangela Iovino; Ulrich Pfisterer; Janice L Holton; Tammaryn Lashley; Robert J Swingler; Laura Calo; Rebecca Treacy; Tamas Revesz; Malin Parmar; Michel Goedert; Miratul M K Muqit; Maria Grazia Spillantini
Journal:  Acta Neuropathol       Date:  2013-11-30       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.